While successful efforts in non-hematologic malignancies have linked radiation sensitivity to genomic classifiers for solid tumors, implicating genes like KEAP1 and CTNNB1 and pathways such as ROS reduction and cell-cycle deregulation, these studies have often explicitly omitted hematologic malignancies (162). Here, KEAP1 is linked to hematologic disorder.